Literature DB >> 7537565

Mast cells, eosinophils and IgE-positive cells in the nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study.

H M Blom1, T Godthelp, W J Fokkens, A Klein Jan, A F Holm, T M Vroom, E Rijntjes.   

Abstract

Vasomotor rhinitis (VMR) is a disorder of unknown pathogenesis. Forty patients with VMR were carefully selected on the basis of inclusion and exclusion criteria proposed by Mygind and Weeke. Nasal biopsy specimens were taken in the patient group as well as in a group of ten controls. Brush cytology was also taken in the VMR group. Inflammatory cells were identified and counted in the nasal mucosa, with the use of immunohistochemical techniques and a panel of monoclonal antibodies. Eosinophils were studied with the use of BMK13, EG2, and Giemsa. Mast cells were studied with anti-chymase (B7), anti-tryptase (G3) and toluidine blue. Sections were stained with IgE as well. There was no significant difference in the number of eosinophils, mast cells and IgE-positive cells between the two groups. Additionally, in contrast with other reports, in sections that were double-stained with anti-chymase and anti-tryptase, single chymase-positive cells were found.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537565     DOI: 10.1007/bf02484432

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  22 in total

1.  Intranasal ipratropium: a new treatment for perennial rhinitis.

Authors:  P Borum; N Mygind; F Schultz Larsen
Journal:  Clin Otolaryngol Allied Sci       Date:  1979-12

Review 2.  Mediator secretion from human skin mast cells provoked by immunological and non-immunological stimulation.

Authors:  M K Church; Y Okayama; S el-Lati
Journal:  Skin Pharmacol       Date:  1991

3.  Observations on the pathogenesis of nasal priming.

Authors:  M Wachs; D Proud; L M Lichtenstein; A Kagey-Sobotka; P S Norman; R M Naclerio
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

4.  The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air.

Authors:  A G Togias; D Proud; L M Lichtenstein; G K Adams; P S Norman; A Kagey-Sobotka; R M Naclerio
Journal:  Am Rev Respir Dis       Date:  1988-03

5.  A biopsy method to obtain high quality specimens of nasal mucosa.

Authors:  W J Fokkens; T M Vroom; V Gerritsma; E Rijntjes
Journal:  Rhinology       Date:  1988-12       Impact factor: 3.681

6.  The effect of submucosal diathermy to the inferior turbinates on nasal resistance to airflow in allergic and vasomotor rhinitis.

Authors:  A S Jones; J M Lancer; A A Moir; J C Stevens
Journal:  Clin Otolaryngol Allied Sci       Date:  1985-10

7.  Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies.

Authors:  A M Irani; T R Bradford; C L Kepley; N M Schechter; L B Schwartz
Journal:  J Histochem Cytochem       Date:  1989-10       Impact factor: 2.479

8.  Capsaicin and nicotine-sensitive afferent neurones and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis.

Authors:  P Stjärne; L Lundblad; J M Lundberg; A Anggård
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

9.  Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season.

Authors:  H Klementsson; C Svensson; M Andersson; P Venge; U Pipkorn; C G Persson
Journal:  Clin Exp Allergy       Date:  1991-11       Impact factor: 5.018

10.  Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study.

Authors:  W J Fokkens; T Godthelp; A F Holm; H Blom; P G Mulder; T M Vroom; E Rijntjes
Journal:  Clin Exp Allergy       Date:  1992-07       Impact factor: 5.018

View more
  10 in total

Review 1.  Capsaicin treatment of idiopathic rhinitis: the new panacea?

Authors:  Jeroen B van Rijswijk; Roy Gerth van Wijk
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

Review 2.  Vasomotor rhinitis.

Authors:  Debendra Pattanaik; Phillip Lieberman
Journal:  Curr Allergy Asthma Rep       Date:  2010-03       Impact factor: 4.806

Review 3.  Nonallergic rhinitis.

Authors:  Phil Lieberman; Debendra Pattanaik
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

Review 4.  [Local (exclusive) IgE production in the nasal mucosa. Evidence for local allergic rhinitis].

Authors:  L Klimek; L von Bernus; O Pfaar
Journal:  HNO       Date:  2013-03       Impact factor: 1.284

5.  Local Allergic Rhinitis in Pediatric Patients: Is IgE Dosage in Nasal Lavage Fluid a Useful Diagnostic Method in Children?

Authors:  Laura Colavita; Natalia Catalano; Giovanna Sposito; Saverio Loddo; Bruno Galletti; Carmelo Salpietro; Francesco Galletti; Caterina Cuppari
Journal:  Int J Mol Cell Med       Date:  2017-09-26

Review 6.  Thoughts on the pathophysiology of nonallergic rhinitis.

Authors:  Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

7.  Pathogenic mechanisms of idiopathic nonallergic rhinitis.

Authors:  James N Baraniuk
Journal:  World Allergy Organ J       Date:  2009-06-15       Impact factor: 4.084

8.  Nasal histamine responses in nonallergic rhinitis with eosinophilic syndrome.

Authors:  Giampietro Zambetti; Andrea Ciofalo; Raffaello Romeo; Pietro Soldo; Massimo Fusconi; Antonio Greco; Giuseppe Magliulo; Marco de Vincentiis
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

9.  Phytomedicine in otorhinolaryngology and pulmonology: clinical trials with herbal remedies.

Authors:  Koosha Ghazi-Moghadam; Hasan Mete Inançlı; Nazanin Bazazy; Peter K Plinkert; Thomas Efferth; Serkan Sertel
Journal:  Pharmaceuticals (Basel)       Date:  2012-08-20

10.  Endotyping of non-allergic, allergic and mixed rhinitis patients using a broad panel of biomarkers in nasal secretions.

Authors:  Christine L Segboer; Wytske J Fokkens; Ingrid Terreehorst; Cornelis M van Drunen
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.